Prostaglandin H2 (PGH2) accelerates formation of amyloid β1−42 oligomers

O Boutaud, JJ Ou, P Chaurand… - Journal of …, 2002 - Wiley Online Library
Journal of neurochemistry, 2002Wiley Online Library
Epidemiologic evidence implicates cyclooxygenase activity in the pathogenesis of
Alzheimer's disease, in which amyloid plaques have been found to contain increased levels
of dimers and higher multimers of the amyloid β peptide. The product of the oxygenation of
arachidonic acid by the cyclooxygenases, prostaglandin H2 (PGH2), rearranges non‐
enzymatically to several prostaglandins, including the highly reactive γ‐keto aldehydes,
levuglandins E2 and D2. We demonstrate that PGH2 markedly accelerates the formation of …
Abstract
Epidemiologic evidence implicates cyclooxygenase activity in the pathogenesis of Alzheimer's disease, in which amyloid plaques have been found to contain increased levels of dimers and higher multimers of the amyloid β peptide. The product of the oxygenation of arachidonic acid by the cyclooxygenases, prostaglandin H2 (PGH2), rearranges non‐enzymatically to several prostaglandins, including the highly reactive γ‐keto aldehydes, levuglandins E2 and D2. We demonstrate that PGH2 markedly accelerates the formation of dimers and higher oligomers of amyloid β1−42. This is associated with the formation of levuglandin adducts of the peptide. These findings provide the molecular basis for a hypothesis linking cyclooxygenase activity to the formation of oligomers of amyloid β.
Wiley Online Library